Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -26.15M | -99.04M | -7.59M | -12.08M | -105.96M |
| Total Depreciation and Amortization | 14.53M | 14.04M | 14.55M | 13.75M | 12.98M |
| Total Amortization of Deferred Charges | 658.00K | 754.00K | 744.00K | 740.00K | 743.00K |
| Total Other Non-Cash Items | 6.34M | 91.58M | 7.49M | -241.00K | 97.65M |
| Change in Net Operating Assets | -10.01M | 5.80M | 2.24M | -10.64M | 2.38M |
| Cash from Operations | -14.64M | 13.14M | 17.43M | -8.47M | 7.79M |
| Capital Expenditure | -5.85M | -8.59M | -9.55M | -5.67M | -16.80M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 918.00K | -368.00K | 3.37M | 1.42M | 3.90M |
| Cash from Investing | -4.93M | -8.96M | -6.18M | -4.24M | -12.90M |
| Total Debt Issued | 953.00K | -- | -- | -- | -- |
| Total Debt Repaid | -230.49M | -1.52M | -1.51M | -1.51M | -1.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -602.00K | -19.00K | -28.00K | -1.43M | -351.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.05M | 2.35M | 1.76M | 2.38M | 2.32M |
| Cash from Financing | -236.19M | 809.00K | 228.00K | -560.00K | 470.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -255.76M | 4.99M | 11.48M | -13.27M | -4.64M |